$YYAI
Connexa Sports Technologies Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223035768 Filed on October 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $2.296M $3.120M
YoY Change -41.94% -36.92%
Cost Of Revenue $1.649M $2.227M
YoY Change -47.7% -37.33%
Gross Profit $647.0K $892.7K
YoY Change -19.27% -35.87%
Gross Profit Margin 28.18% 28.61%
Selling, General & Admin $1.921M $2.747M
YoY Change -68.84% -50.43%
% of Gross Profit 296.98% 307.75%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.921M $2.747M
YoY Change -73.41% -56.92%
Operating Profit -$1.274M -$1.855M
YoY Change -80.16% -62.79%
Interest Expense $3.050M $2.080M
YoY Change -402.1%
% of Operating Profit
Other Income/Expense, Net $3.037M $1.008M
YoY Change -166.01% 40.32%
Pretax Income $1.762M -$846.8K
YoY Change -115.99% -80.15%
Income Tax
% Of Pretax Income
Net Earnings $1.762M -$846.8K
YoY Change -115.99% -80.15%
Net Earnings / Revenue 76.75% -27.14%
Basic Earnings Per Share -$14.29 -$1.93
Diluted Earnings Per Share -$14.29 -$1.93
COMMON SHARES
Basic Shares Outstanding 774.0K shares 19.39M shares
Diluted Shares Outstanding 912.1K shares 438.4K shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $285.9K $390.0K
YoY Change -38.53% -75.66%
Cash & Equivalents $285.9K $386.5K
Short-Term Investments
Other Short-Term Assets $980.6K $1.420M
YoY Change -50.25% -36.41%
Inventory $1.668M $2.337M
Prepaid Expenses
Receivables $528.0K $444.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.463M $4.583M
YoY Change -56.98% -63.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.001M $2.001M
YoY Change -96.72% -96.75%
TOTAL ASSETS
Total Short-Term Assets $3.463M $4.583M
Total Long-Term Assets $2.001M $2.001M
Total Assets $5.464M $6.584M
YoY Change -92.09% -91.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.113M $6.087M
YoY Change -10.48% -7.59%
Accrued Expenses $5.047M $5.197M
YoY Change -33.16% -22.65%
Deferred Revenue
YoY Change
Short-Term Debt $3.195M $1.960M
YoY Change 297.51% -49.3%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $18.46M $23.30M
YoY Change -35.65% 1.13%
LONG-TERM LIABILITIES
Long-Term Debt $1.399M $1.660M
YoY Change -30.06% -17.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $1.399M $1.656M
YoY Change -56.38% -50.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.46M $23.30M
Total Long-Term Liabilities $1.399M $1.656M
Total Liabilities $19.86M $24.95M
YoY Change -37.73% -5.33%
SHAREHOLDERS EQUITY
Retained Earnings -$150.8M -$152.6M
YoY Change 57.31% 79.82%
Common Stock $136.2M $134.1M
YoY Change 2.58% 1.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$14.40M -$18.37M
YoY Change
Total Liabilities & Shareholders Equity $5.464M $6.584M
YoY Change -92.09% -91.12%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $1.762M -$846.8K
YoY Change -115.99% -80.15%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$918.1K $267.2K
YoY Change -71.23% -108.08%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.254M -$601.0K
YoY Change -35.3% -117.64%
NET CHANGE
Cash From Operating Activities -918.1K $267.2K
Cash From Investing Activities
Cash From Financing Activities 1.254M -$601.0K
Net Change In Cash 336.4K -$351.8K
YoY Change -126.86% -309.21%
FREE CASH FLOW
Cash From Operating Activities -$918.1K $267.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001674440
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--04-30
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
usd
CY2022Q3 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
usd
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
usd
CY2023Q3 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
usd
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
CY2022Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
usd
CY2023Q3 CNXA Stock Issued During Period Value Cashless Exercise Of Warrants
StockIssuedDuringPeriodValueCashlessExerciseOfWarrants
usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2023Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
CY2022Q3 CNXA Settlement Expense
SettlementExpense
usd
CY2022Q3 CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
usd
CY2023Q3 CNXA Gain Loss On Issuance Of Convertible Notes
GainLossOnIssuanceOfConvertibleNotes
usd
CY2022Q3 CNXA Gain Loss On Issuance Of Convertible Notes
GainLossOnIssuanceOfConvertibleNotes
usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q3 CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2022Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
usd
CY2022Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
usd
CY2022Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2023Q3 CNXA Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
usd
CY2022Q3 CNXA Increase Decrease In Interest Payable Related Party
IncreaseDecreaseInInterestPayableRelatedParty
usd
CY2023Q3 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
CY2022Q3 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2023Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q3 CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
usd
CY2023Q3 CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
usd
CY2022Q3 CNXA Shares Issued For Settlement Of Accounts Payable
SharesIssuedForSettlementOfAccountsPayable
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-07-31
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
01-41423
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
CONNEXA SPORTS TECHNOLOGIES INC.
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1789640
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2709 NORTH ROLLING ROAD
CY2023Q3 dei Entity Address Address Line2
EntityAddressAddressLine2
SUITE 138
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
WINDSOR MILL
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21244
CY2023Q3 dei City Area Code
CityAreaCode
(443)
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
407-7564
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
CY2023Q3 dei Trading Symbol
TradingSymbol
CNXA
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
773975 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
386459 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
202095 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
444622 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
399680 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2336918 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2023Q3 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
1134368 usd
CY2023Q2 CNXA Prepaid Inventory Current
PrepaidInventoryCurrent
936939 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
280820 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263020 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
4583187 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
4991500 usd
CY2023Q3 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Other Receivables
OtherReceivables
2000000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14791 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
101281 usd
CY2023Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2001000 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
2116072 usd
CY2023Q3 us-gaap Assets
Assets
6584187 usd
CY2023Q2 us-gaap Assets
Assets
7107572 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6087311 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5496629 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5197460 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2023Q3 us-gaap Notes Payable Current
NotesPayableCurrent
1959671 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1484647 usd
CY2023Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
8345052 usd
CY2023Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
10489606 usd
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
418455 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
418455 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
330065 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
22971 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
23297493 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
23767491 usd
CY2023Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1655966 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1953842 usd
CY2023Q3 us-gaap Liabilities
Liabilities
24953459 usd
CY2023Q2 us-gaap Liabilities
Liabilities
25721333 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
528297 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528297 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
528 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
339 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
134112083 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
132993998 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152597375 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151750610 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
115492 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
142512 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6584187 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7107572 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3120231 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3583336 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2227482 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2562044 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
892749 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
1021292 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
242353 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
756823 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2505060 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3314610 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
19425 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2747413 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
4090858 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1854664 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3069566 usd
CY2023Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-777192 usd
CY2022Q3 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
-2872222 usd
CY2023Q3 CNXA Loss On Conversion Of Accounts Payable To Common Stock
LossOnConversionOfAccountsPayableToCommonStock
-289980 usd
CY2023Q3 CNXA Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
2144554 usd
CY2022Q3 CNXA Gain Loss On Change In Fair Value Of Derivatives Liability
GainLossOnChangeInFairValueOfDerivativesLiability
3687495 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1007899 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
562849 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-846765 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2506717 usd
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation During Phase Out Period Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodBeforeIncomeTax
-1759714 usd
CY2022Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-1759714 usd
CY2023Q3 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-846765 usd
CY2022Q3 CNXA Income Loss From Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4266431 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58139 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-873785 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4208292 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.93
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.93
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-14.27
CY2022Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-14.27
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-10.02
CY2022Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-10.02
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-24.29
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-24.29
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
438354 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
438354 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
175653 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
175653 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
32511932 usd
CY2022Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
14046300 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
915545 usd
CY2022Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
35250 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
4195000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
277625 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58139 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
58139 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
47773360 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-18613761 usd
CY2023Q3 CNXA Stock Issued During Period Value Accounts Payable
StockIssuedDuringPeriodValueAccountsPayable
559980 usd
CY2023Q3 CNXA Stock Issued During Period Value Satisfaction Of Profit Guarantee On Note Payable
StockIssuedDuringPeriodValueSatisfactionOfProfitGuaranteeOnNotePayable
558294 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-27020 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-18369272 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-846765 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-4266431 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
115072 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2144554 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
3687495 usd
CY2022Q3 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
35250 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
277625 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
777192 usd
CY2022Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2872222 usd
CY2023Q3 CNXA Settlement Expense
SettlementExpense
558294 usd
CY2023Q3 CNXA Loss On Settlement Of Accounts Payable
LossOnSettlementOfAccountsPayable
289980 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-265992 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-852848 usd
CY2023Q3 CNXA Increase Decrease In Prepaid Inventory
IncreaseDecreaseInPrepaidInventory
197429 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1316 usd
CY2023Q3 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
255199 usd
CY2023Q3 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
326550 usd
CY2023Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
16135 usd
CY2023Q3 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
1113963 usd
CY2022Q3 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-502398 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
267198 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4768829 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
267198 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4768829 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4195000 usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
925000 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
298834 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
15386 usd
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
302168 usd
CY2022Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1698485 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-601002 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3406129 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-17996 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67357 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-351800 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1295343 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
202095 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
665002 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-149705 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-630341 usd
CY2022Q3 CNXA Conversion Of Convertible Notes Payable And Accrued Interest To Common Stock
ConversionOfConvertibleNotesPayableAndAccruedInterestToCommonStock
14046300 usd
CY2022Q3 CNXA Shares Issued For Contingent Consideration
SharesIssuedForContingentConsideration
915545 usd
CY2023Q3 CNXA Shares Issued For Settlement Of Accounts Payable
SharesIssuedForSettlementOfAccountsPayable
270000 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-10 reverse stock split
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-152597375 usd
CY2023Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zIkrIaVahK7d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86C_zzrlLoow2ZNe">Use of Estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Accordingly, actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84A_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zr5w94rNkM43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_86F_zbnq689LntWg">Financial Statement Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior year amounts within accounts payable, accrued expenses, and certain operating expenses have been reclassified for consistency with the current year presentation and had no effect on the Company’s balance sheet, net loss, shareholders’ deficit or cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
200000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
209690 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
400598 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1509985 usd
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
2064041 usd
CY2023Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1712553 usd
CY2023Q3 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
47279 usd
CY2023Q2 CNXA Capitalized Duty And Freight
CapitalizedDutyAndFreight
517228 usd
CY2023Q3 us-gaap Inventory Adjustments
InventoryAdjustments
175000 usd
CY2023Q2 us-gaap Inventory Adjustments
InventoryAdjustments
550000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
2336918 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
3189766 usd
CY2023Q3 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P5Y
CY2023Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcbmzjBRP1f3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline"><span id="xdx_866_zuHXeODpB3a4">Concentration of Credit Risk</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash in bank deposit accounts, the balances of which at times may exceed insured limits. The Company continually monitors its banking relationships and consequently has not experienced any losses in such accounts. While we may be exposed to credit risk, we consider the risk remote and do not expect that any such risk would result in a significant effect on our results of operations or financial condition. See Note 4 for further details on the Company’s concentration of credit risk as well as other risks and uncertainties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Derivative Instruments And Hedges Liabilities
DerivativeInstrumentsAndHedgesLiabilities
8345052 usd
CY2023Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2144554 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1000 usd
CY2023Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
100281 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
14791 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1445 usd
CY2023Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1754936 usd
CY2023Q2 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
1535186 usd
CY2023Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1829604 usd
CY2023Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1720606 usd
CY2023Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
35000 usd
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
490424 usd
CY2023Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1577920 usd
CY2023Q2 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
1165623 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5197460 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4911839 usd
CY2023Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
2092700 usd
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Warrants Or Options Issued1
DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1
13200000 shares
CY2022Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
846301 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
122222 usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1501914 usd
CY2021Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1250004 usd
CY2022Q1 us-gaap Business Combination Consideration Transferred Other1
BusinessCombinationConsiderationTransferredOther1
4000000 usd
CY2022Q1 CNXA Number Of Consigned Goods
NumberOfConsignedGoods
13000 integer
CY2023 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
4000000 usd
CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
1559109 usd
CY2022Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2022-07-01
CY2022Q3 CNXA Payments Of Related Party Debt
PaymentsOfRelatedPartyDebt
500000 usd
CY2023Q3 CNXA Increase Decrease In Derivative Fair Value Liability
IncreaseDecreaseInDerivativeFairValueLiability
675072 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Increase Decrease
DebtInstrumentInterestRateIncreaseDecrease
0.0643 pure
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
528297 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
528297 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
338579 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
338579 shares
CY2023Q3 us-gaap Shares Issued
SharesIssued
189718 shares
CY2023Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188 usd
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement Of Accounts Payable
StockIssuedDuringPeriodSharesIssuedSettlementOfAccountsPayable
67500 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Settlement With Former Owners
StockIssuedDuringPeriodSharesIssuedSettlementWithFormerOwners
1350 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
27000 shares
CY2023Q3 CNXA Stock Issued During Period Shares Issued Profit Guarantee On Note
StockIssuedDuringPeriodSharesIssuedProfitGuaranteeOnNote
93680 shares
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
151579 shares
CY2022Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
109737 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
48098 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
675 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
6993 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
150 shares
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
1969 usd
CY2022Q3 us-gaap Payments For Rent
PaymentsForRent
700 usd
CY2023Q1 CNXA Fair Value Of Common Stock
FairValueOfCommonStock
1334000 usd
CY2022Q2 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
14960 shares
CY2023Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
418455 usd
CY2023Q1 CNXA Minimum Bid Price
MinimumBidPrice
1.00
CY2023Q1 CNXA Minimum Bid Price
MinimumBidPrice
1.00
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
11700000 usd
CY2022Q4 us-gaap Cash
Cash
500000 usd
CY2022Q4 us-gaap Investments
Investments
500000 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
1363113 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
3278269 usd
CY2023Q3 CNXA Disposal Group Including Discontinued Operation Other Income Loss
DisposalGroupIncludingDiscontinuedOperationOtherIncomeLoss
-155442 usd
CY2023Q3 CNXA Disposal Group Including Discontinued Operation Net Income Loss
DisposalGroupIncludingDiscontinuedOperationNetIncomeLoss
-1759714 usd

Files In Submission

Name View Source Status
cnxa-20230731_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
cnxa-20230731_lab.xml Edgar Link unprocessable
0001493152-23-035768-index-headers.html Edgar Link pending
0001493152-23-035768-index.html Edgar Link pending
0001493152-23-035768.txt Edgar Link pending
0001493152-23-035768-xbrl.zip Edgar Link pending
cnxa-20230731.xsd Edgar Link pending
ex10-1.htm Edgar Link pending
ex10-1_001.jpg Edgar Link pending
ex10-1_002.jpg Edgar Link pending
ex10-1_003.jpg Edgar Link pending
ex10-1_004.jpg Edgar Link pending
ex10-1_005.jpg Edgar Link pending
ex10-1_006.jpg Edgar Link pending
ex10-1_007.jpg Edgar Link pending
ex10-1_008.jpg Edgar Link pending
ex10-1_009.jpg Edgar Link pending
ex10-1_010.jpg Edgar Link pending
ex10-1_011.jpg Edgar Link pending
ex10-1_012.jpg Edgar Link pending
ex10-1_013.jpg Edgar Link pending
ex10-1_014.jpg Edgar Link pending
ex10-1_015.jpg Edgar Link pending
ex10-1_016.jpg Edgar Link pending
ex10-1_017.jpg Edgar Link pending
ex10-1_018.jpg Edgar Link pending
ex10-1_019.jpg Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2_001.jpg Edgar Link pending
ex10-2_002.jpg Edgar Link pending
ex10-2_003.jpg Edgar Link pending
ex10-2_004.jpg Edgar Link pending
ex10-2_005.jpg Edgar Link pending
ex10-2_006.jpg Edgar Link pending
ex10-2_007.jpg Edgar Link pending
ex10-2_008.jpg Edgar Link pending
ex10-2_009.jpg Edgar Link pending
ex10-2_010.jpg Edgar Link pending
ex10-2_011.jpg Edgar Link pending
ex10-2_012.jpg Edgar Link pending
ex10-2_013.jpg Edgar Link pending
ex10-2_014.jpg Edgar Link pending
ex10-2_015.jpg Edgar Link pending
ex10-2_016.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-3_001.jpg Edgar Link pending
ex10-3_002.jpg Edgar Link pending
ex10-3_003.jpg Edgar Link pending
ex10-3_004.jpg Edgar Link pending
ex10-3_005.jpg Edgar Link pending
ex10-3_006.jpg Edgar Link pending
ex10-3_007.jpg Edgar Link pending
ex10-3_008.jpg Edgar Link pending
cnxa-20230731_pre.xml Edgar Link unprocessable
cnxa-20230731_def.xml Edgar Link unprocessable
ex10-3_009.jpg Edgar Link pending
ex10-3_010.jpg Edgar Link pending
ex10-3_011.jpg Edgar Link pending
ex10-3_012.jpg Edgar Link pending
ex10-3_013.jpg Edgar Link pending
ex10-3_014.jpg Edgar Link pending
ex10-3_015.jpg Edgar Link pending
ex10-3_016.jpg Edgar Link pending
ex10-3_017.jpg Edgar Link pending
ex10-3_018.jpg Edgar Link pending
ex10-3_019.jpg Edgar Link pending
ex10-3_020.jpg Edgar Link pending
ex10-3_021.jpg Edgar Link pending
ex10-3_022.jpg Edgar Link pending
ex10-3_023.jpg Edgar Link pending
ex10-3_024.jpg Edgar Link pending
ex3-1.htm Edgar Link pending
ex3-1_001.jpg Edgar Link pending
ex3-1_002.jpg Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending